Epidural Abscess Treatment Market Size

  • Report ID: 3437
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Epidural Abscess Treatment Market Size

Epidural Abscess Treatment Market size was over USD 41.61 Billion in 2023 and is poised to reach USD 135.39 Billion by the end of 2036, witnessing around 9.5% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of epidural abscess treatment is assessed at USD 45.17 Billion. The growth of the market can be attributed to the increasing stances of epidural abscesses throughout the world. For instance, in 2022, around 0.7 to 1.8 cases of spinal epidural abscesses were reported for every 10,000 hospital admissions across the globe. Furthermore, the rapid increase in medical research and development activities and the significant rise in the aged populace are also estimated to drive market growth over the forecast period.

In addition to these, factors that are believed to fuel the market growth of epidural abscess treatment include the worldwide expansion in spinal surgeries. For instance, globally approximately 350 million spinal surgeries were performed in 2022. In addition to this, rising risks of infection caused by back and head surgeries are also estimated to boost the market growth in the coming years. Besides this, the surging cases of chronic ear infections are also anticipated to fuel the market growth as the such infection starts with swelling, severe pain, or an infection behind the eardrum which can permanently damage the eardrum.


Epidural Abscess Treatment Market Overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3437
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of epidural abscess treatment is assessed at USD 45.17 Billion.

The epidural abscess treatment market size was over USD 41.61 Billion in 2023 and is poised to reach USD 135.39 Billion by the end of 2036, witnessing around 9.5% CAGR during the forecast period i.e., between 2024-2036. The surge in head surgeries, rising cases of otitis media, and increasing ratio of traumatic brain injury are the major factors driving the market growth.

North America is predicted to be the largest with a share of about 38% by 2036, propelled by high healthcare expenditure, followed by rising frequency of epidural abscess cases in the region.

Alembic Limited, Eli Lilly and Company, Sandoz Inc., Sun Pharmaceutical Industries Limited, Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Pfizer Inc., Siemens Healthcare GmbH
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample